[go: up one dir, main page]

NO974400D0 - Combination preparations containing benazepril or benazeprilat and valsartan - Google Patents

Combination preparations containing benazepril or benazeprilat and valsartan

Info

Publication number
NO974400D0
NO974400D0 NO974400A NO974400A NO974400D0 NO 974400 D0 NO974400 D0 NO 974400D0 NO 974400 A NO974400 A NO 974400A NO 974400 A NO974400 A NO 974400A NO 974400 D0 NO974400 D0 NO 974400D0
Authority
NO
Norway
Prior art keywords
benazeprilat
valsartan
preparations containing
combination preparations
containing benazepril
Prior art date
Application number
NO974400A
Other languages
Norwegian (no)
Other versions
NO974400L (en
Inventor
Marc De Gasparo
Randy Lee Webb
David Saul Cohen
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO974400L publication Critical patent/NO974400L/en
Publication of NO974400D0 publication Critical patent/NO974400D0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55Protease inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55Protease inhibitors
    • A61K38/556Angiotensin converting enzyme inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO974400A 1995-04-07 1997-09-23 Combination preparations containing benazepril or benazeprilat and valsartan NO974400D0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH101295 1995-04-07
PCT/EP1996/001440 WO1996031234A1 (en) 1995-04-07 1996-04-02 Combination compositions containing benazepril or benazeprilat and valsartan

Publications (2)

Publication Number Publication Date
NO974400L NO974400L (en) 1997-09-23
NO974400D0 true NO974400D0 (en) 1997-09-23

Family

ID=4200393

Family Applications (1)

Application Number Title Priority Date Filing Date
NO974400A NO974400D0 (en) 1995-04-07 1997-09-23 Combination preparations containing benazepril or benazeprilat and valsartan

Country Status (15)

Country Link
EP (1) EP0820302A1 (en)
JP (1) JPH11503139A (en)
KR (1) KR19980703647A (en)
CN (1) CN1181019A (en)
AU (1) AU5399096A (en)
BR (1) BR9604818A (en)
CA (1) CA2214143A1 (en)
CZ (1) CZ313897A3 (en)
HU (1) HUP9801593A2 (en)
MX (1) MX9707683A (en)
NO (1) NO974400D0 (en)
PL (1) PL322529A1 (en)
SK (1) SK133897A3 (en)
TR (1) TR199701121T1 (en)
WO (1) WO1996031234A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2224451A1 (en) * 1995-06-30 1997-01-23 Merck & Co., Inc. Method of treating renal disease using an ace inhibitor and an aii antagonist
CN101011390A (en) 1999-01-26 2007-08-08 诺瓦提斯公司 Use of angiotensin II receptor antagonists for treating acute myocardial infarction
KR20020089433A (en) * 2000-04-12 2002-11-29 노파르티스 아게 Combination of Organic Compounds
PE20020613A1 (en) * 2000-07-19 2002-08-07 Novartis Ag SALTS OF (S) -N- (1-CARBOXY-2-METHYL-PROP-1-IL) -N-PENTANOYL-N- [2 '- (1H-TETRAZOLE-5-IL) -BIPHENYL-4-ILMETHYL] -AMINE AS ANTAGONIST OF THE AT1 RECEPTOR
EA200300224A1 (en) * 2000-08-22 2003-08-28 Бёрингер Ингельхайм Фарма Гмбх Унд Ко. Кг PHARMACEUTICAL COMBINATION OF ANTAGONISTS OF ANGIOTENZINE II AND ACE INHIBITORS
GB0020691D0 (en) * 2000-08-22 2000-10-11 Boehringer Ingelheim Pharma Pharmaceutical combination
KR20040007420A (en) * 2000-12-18 2004-01-24 노파르티스 아게 Therapeutic combination of Amlodipine and Benazepril
US6869970B2 (en) 2002-02-04 2005-03-22 Novartis Ag Crystalline salt forms of valsartan
CN1465712A (en) * 2002-07-05 2004-01-07 安徽省生物医学研究所 Kit for5 forecasting ACEI group hypotensor effect, method, software and compound medicine thereof
AU2003268219B2 (en) * 2002-08-28 2009-09-24 Barnes-Jewish Hospital Conjoint administration of morphogens and ACE inhibitors in treatment of chronic renal failure
EP1908469A1 (en) 2006-10-06 2008-04-09 Boehringer Ingelheim Vetmedica Gmbh Angiotensin II receptor antagonist for the treatment of systemic diseases in cats
CN101869710A (en) * 2009-04-24 2010-10-27 北京奥萨医药研究中心有限公司 Antihypertensive medical composite
EP2432452B1 (en) 2009-05-20 2016-07-27 Boehringer Ingelheim Vetmedica GmbH Pharmaceutical telmisartan drink solution
US20110009347A1 (en) 2009-07-08 2011-01-13 Yin Liang Combination therapy for the treatment of diabetes
WO2015116880A1 (en) * 2014-01-31 2015-08-06 Janssen Pharmaceutica Nv Methods for the treatment and prevention of renal disorders and fatty liver disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0729938B2 (en) * 1990-05-11 1995-04-05 フアイザー・インコーポレイテツド Synergistic therapeutic compositions and methods
EP0629408A1 (en) * 1993-06-16 1994-12-21 LABORATOIRES MERCK, SHARP & DOHME-CHIBRET Combination of angiotensin converting enzyme inhibitors and AII antagonists

Also Published As

Publication number Publication date
CN1181019A (en) 1998-05-06
CZ313897A3 (en) 1998-01-14
KR19980703647A (en) 1998-12-05
NO974400L (en) 1997-09-23
EP0820302A1 (en) 1998-01-28
PL322529A1 (en) 1998-02-02
AU5399096A (en) 1996-10-23
CA2214143A1 (en) 1996-10-10
WO1996031234A1 (en) 1996-10-10
TR199701121T1 (en) 1998-03-21
HUP9801593A2 (en) 1999-01-28
JPH11503139A (en) 1999-03-23
BR9604818A (en) 1998-06-09
MX9707683A (en) 1997-12-31
SK133897A3 (en) 1998-02-04

Similar Documents

Publication Publication Date Title
GB2298422B (en) Compounds and their use
DE69731559D1 (en) FACE AND BREATH PROTECTION SYSTEM
IS4481A (en) Dihydropyramidine and their use
DE59608189D1 (en) Respirator
NO973216L (en) Substituted oxazolidine-calpain and / or cathepsin B inhibitors
IL122813A0 (en) Thrombin inhibitors their preparation and use
DK0804078T3 (en) Composition and use thereof
DK0741005T3 (en) Composite film and its use
NO974400D0 (en) Combination preparations containing benazepril or benazeprilat and valsartan
GB2304309B (en) Laminate and use thereof
NO960847L (en) Mooring and connecting system
DE69620243D1 (en) MAIN AND BY-FLOW FILTER
FI960270A (en) Improvements to ships and related
FR2739382B1 (en) RIBOSOMAL FRACTION AND COMPOSITION CONTAINING THE SAME
NO995374D0 (en) Ferrosenic-dicarboxylic acid diesters and composite solids containing these
KR960029575U (en) Lost and lost items
IL112773A0 (en) Parallel balance systems and improvements to parallel balance systems
EP0777523A4 (en) Self-emulsifying and/or emollient agents
HU9500363D0 (en) Personal alarm
KR950027796U (en) US Window and Rescue
NO302753B1 (en) Tetrazole derivatives and their use
FI925598A0 (en) Multiplexer and demultiplexer
FI952222A0 (en) Foerfarande and anordingar Foer att laengsriktat omsluta en metal-ledare med en eller flera isolerfilmer
HU2381U (en) Mammer in case of emergency
IL126309A0 (en) Parallel balance systems and improvements to parallel balance systems